A bisphosphonate for the treatment of osteonecrosis and/or osteonecrosis dissecans. The drug may further he used to prevent the onset of osteonecrosis and/or osetonecrosis dissecans and any complications associated with both diseases.
Web www.patentalert.com
< Methods for identifying cancer risk
> Crystalline forms of the anti-cancer compound ZD1839
> Polymeric compositions and uses therefor
HOME | NEW USER | LOGIN | SUBSCRIPTIONS | SEARCH | GUESTBOOK | CONTACT